Digital Health Startups

Glance Care is a health insurance technology company founded in 2019 that develops digital solutions for the Saudi Arabian healthcare system. The company focuses on making health insurance more accessible and affordable through innovative technology and data analytics.

1 investor

GLIA Diagnostics is an Australian medtech company developing a point-of-care platform that uses a multiplex circulating microRNA biomarker panel to provide objective biological information following traumatic brain injury, including mild TBI and concussion. The system, still investigational, combines a blood sample, cartridge and handheld reader targeting an approximately 20-minute result for use in clinical, sport and defence settings.

1 investor

Glimmer is a mental health company that provides access to psychotherapy and clinical mental health care. The company connects clients with experienced therapists for evidence-based treatment of conditions including trauma, PTSD, anxiety, and depression.

1 investor

IHME is an independent research institute at the University of Washington School of Medicine that generates scientific evidence on global health outcomes, disease burden, and forecasting to inform policy and health system decisions. The organization develops health metrics, applies AI and statistical methods to health data analysis, and studies health system capacity, climate impacts on health, and health equity across populations worldwide.

1 investor

Global Health Uganda is a not-for-profit research organization that provides infrastructure, management systems, and capacity-building support for scientists conducting research on child health, neurodevelopment, and interventions. Based in Uganda, the organization facilitates collaborative research and manages research grants for health scientists.

1 investor

Gloria.care runs an online platform for finding and booking care accommodations (such as short-term or respite care stays), connecting families and informal caregivers with care providers. It also serves hospitals and care professionals who need to refer patients who cannot (temporarily) return home after hospitalization, and lets families leave reviews on service quality.

1 investor

Glucose Republic builds software that predicts an individual's postprandial glucose and digestive response to whole meals before eating, modeling food matrices, digestive kinetics, and circadian physiology rather than relying on retrospective calorie logging. It is aimed at people managing blood glucose and diabetes, developed with medical device rigor and patent-pending prediction methods.

1 investor

GlucoSentient develops diagnostic assays based on functional DNA (DNAzymes and aptamers) and nanomaterials for sensing applications. The company applies this biosensing technology to the diagnostics and medical testing field.

1 investor

GLX Analytix develops a blood test platform that measures glycocalyx fragments and uses AI/ML to create disease-specific biomarker signatures for diagnosing and monitoring brain diseases including neuropsychiatric, neurodegenerative, and autoimmune conditions. The company targets clinicians and healthcare providers seeking early detection and precision medicine insights for conditions like Parkinson's, multiple sclerosis, schizophrenia, and stroke.

1 investor

Glya provides a remote patient monitoring platform that captures clinical data, vital signs, and biomarkers at home for chronic and acute patients, using an optional Bluetooth IoT gateway connected to biomedical devices and a WhatsApp-based AI assistant. Its PXM product manages patient cohorts, integrates with electronic health records via HL7 FHIR, and applies analytics and machine learning to detect deterioration early for healthcare organizations.

1 investor

Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer. The company operates in the biomedical diagnostics field within the healthcare industry.

1 investor

Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity. Its approach originated from research on how certain bariatric surgeries improve glucose and metabolic regulation and produce sustained weight loss.

1 investor

Town WiFi operates a free public WiFi network service for users to access WiFi at partner locations. The company also develops related mobile applications and services including loyalty and rewards programs.

1 investor

Gnosis Health builds longitudinal clinical intelligence tools that provide continuous, individualised care between medical appointments, focused on chronic disease management. The company applies health data analysis to support patients with long-term conditions.

1 investor

Aitia builds the Gemini Digital Twin platform, which combines causal AI and a reverse-engineering/forward-simulation (REFS) engine with supercomputing and patient multiomic and clinical data to create in silico models of human disease biology. The models identify novel causal drug targets and biomarkers that biopharma partners use to develop precision drugs for oncological, neurodegenerative, immunological, and cardiometabolic diseases.

1 investor

Goally makes a child-focused tablet and app suite with visual schedules, chore charts, and games that teach executive function, emotional regulation, speech, and life skills. It is aimed at parents of toddlers and young children (ages 2–8), including kids with developmental needs, offering an ad-free, closed ecosystem device.

1 investor

GoDocta is a full-stack healthcare access platform combining a two-sided telemedicine marketplace, cross-border electronic health records, AI-assisted clinical decision support, care coordination, and digital prescriptions. It serves patients and physicians in the Caribbean, Latin America, and other underserved markets, and operates its own clinic (UCare SKN in St. Kitts & Nevis) alongside its technology layer.

1 investor

Goldie Health develops workflow automation and analytics solutions for opioid crisis response teams and addiction treatment providers. The company focuses on expanding access to evidence-based substance use disorder treatment and overdose prevention through technology and clinical integration.

1 investor

Gomanda is an at-home special education app offering a gamified, personalized curriculum and speech therapy for children, including augmentative and alternative communication (AAC) tools for kids with autism spectrum disorder. It is designed to be ad-free and parent-controlled, and supports the process of attending public schools.

1 investor

Good Doctor is an Indonesian telemedicine service offering 24/7 access to health professionals, an online health store, medication delivery, and specialist bookings across more than 200 cities. It also provides corporate solutions for outpatient care and employee health benefits, backed by a network of 6,000+ doctors, 4,000+ pharmacies, and labs in 100+ cities.

1 investor

GoodCap Pharmaceuticals develops drug candidates targeting disorders driven by neuroinflammation, with a lead candidate (GCAP001) combining two molecule classes to reduce inflammatory biomarkers linked to psychiatric and neurodegenerative conditions. Its initial focus is on treating PTSD.

1 investor

GoodGut develops intellectual property based on the study of individuals' gut microbiota, which plays a role in intestinal immunity and the development of digestive diseases. The company aims to provide diagnostic solutions for digestive conditions to the healthcare system.

1 investor

Scribble provides AI-powered clinical documentation software for home health agencies, capturing bedside information to automate OASIS forms and reduce administrative burden on clinicians. The platform handles post-acute care documentation, billing, and compliance workflows in the Medicare home health sector.

1 investor

Gossik offers a mobile app for people with ADHD that provides evidence-based strategies, an AI-powered chat, a peer community with body doubling sessions, and matching with ADHD coaches. The app is aimed at adults managing daily life with ADHD.

1 investor